← Search & browse all drugs
DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Antibiotics
griseofulvin
D01AA08
Forms & Strengths
- Tablets (Microsize): 125 mg, 250 mg, 500 mg
- Tablets (Ultramicrosize): 125 mg, 165 mg, 250 mg, 330 mg
- Oral Suspension (Microsize): 125 mg/5 mL
Adult Dosing
- Tinea corporis, tinea cruris, tinea capitis (Microsize): 500 mg daily in single or divided doses
- Tinea pedis, tinea unguium (Microsize): 500 mg to 1000 mg daily in single or divided doses
- Ultramicrosize equivalents: 330 mg to 375 mg daily, adjusted based on severity and clinical response
Pediatric Dosing
- Children > 2 years (Microsize): 10 mg/kg to 15 mg/kg daily in single or divided doses
- Children > 2 years (Ultramicrosize): 5.5 mg/kg to 7.3 mg/kg daily in single or divided doses
Indications
- Treatment of dermatophytosis of the skin, hair, and nails (tinea capitis, tinea corporis, tinea cruris, tinea pedis, and tinea unguium)
- Effective only against dermatophyte infections caused by Microsporum, Trichophyton, and Epidermophyton species
Mechanism of Action
- Binds to keratin in newly forming skin, hair, and nails, rendering them unfavorable for fungal growth
- Inhibits fungal mitosis by disrupting the mitotic spindle structure through interaction with polymerized microtubules
Contraindications
- Hypersensitivity to griseofulvin or any component of the formulation
- Severe liver disease
- Porphyria
- Pregnancy
Adverse Reactions
- Central nervous system: Headache, dizziness, fatigue, confusion, insomnia
- Gastrointestinal: Nausea, vomiting, diarrhea, epigastric distress, dry mouth
- Dermatologic: Rash, urticaria, photosensitivity, erythema multiforme, toxic epidermal necrolysis
- Hematologic: Leukopenia, neutropenia, granulocytopenia
- Hepatic: Elevated transaminases, hepatotoxicity, intrahepatic cholestasis
Drug Interactions
- Warfarin: Decreases anticoagulant response; monitor INR and adjust warfarin dosage accordingly
- Oral contraceptives: May reduce efficacy of estrogen-containing contraceptives, leading to breakthrough bleeding or contraceptive failure
- Barbiturates: Decrease absorption and therapeutic efficacy of griseofulvin
- Ethanol: May cause flushing and tachycardia (disulfiram-like reaction)
- Salicylates: May decrease serum salicylate concentrations
Curated Content: Needs Vetting Before Put to Clinical Use